Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

PML-IRIS in a rare myeloma subtype, the non-secretory multiple myeloma (NSMM)

Congresso Regionale Fadoi Campania 2023 Cdc 231 (proceedings of XXII Congress of Fadoi Campania)
22 September 2023, Italy

E. Marrone, R. Della Pepa, G. Maniscalco, F. Gallucci, U. Malgeri, C.Romano, F. Zeccolini, P. Morella

Internal Medicine Unit 3, A. Cardarelli Hospital, Naples
Department of Hematology, Federico II University Hospital, Naples, Italy
Multiple Sclerosis Regional Center, �??A. Cardarelli�?� Hospital, Naples, Italy
Neuroradiology Unit, �??A. Cardarelli�?� Hospital, Naples, Italy

Scientific Tracks Abstracts: Health Sci J

Abstract:

Background Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic infection caused by John Cunningham virus (JCV) in the context of immunosuppression such as HIV, malignancy, and certain immunomodulatory medication. PML has been reported only rarely in multiple myeloma (MM) patients. We describe a rare case of PML with immune reconstitution inflammatory syndrome (IRIS) in a patient with non-secretory multiple myeloma (NSMM). Case report A 65-year-old woman with a medical story of NSMM for about 10 years, treated with multiple lines of chemotherapy and undergoing two autologous stem cell transplants, now refractory, was admitted to the hospital presenting confusion, short-term memory impairment and behavioral changes. CT head showed bilateral white matter changes raising the possibility of central nervous system (CNS) infection or intraparenchymal CNS myeloma infiltration. MRI brain revealed multiple areas of hyper intensity on T2-weighted sequences which did not enhance but many of which showed diffusion restriction suggesting for PMLIRIS. A lumbar puncture was undertaken. Cerebrospinal fluid was positive for the JCV confirming the diagnosis of PML. Because patient presented PML-IRIS, steroid therapy was prescribed with a modest benefit. Three months later the patient died of a massive cerebral haemorrhage. Conclusions PML in MM is a rare consequence of the disease and its immunosuppressive profile, but it is underdiagnosed. Thus, an appropriate clinical approach compatible with early investigation and diagnosis and treatment of PML should be developed.